Filling a real knowledge gap, this handbook and ready reference is both modern and forward-looking in its emphasis on the "bench to bedside" translational approach to drug development.
Clearly structured into three major parts, the book stakes out the boundaries of peptide drug development in the preclinical as well as clinical stages. The first part provides a general background and focuses on the characteristic strengths and weaknesses of peptide drugs. The second section contains five cases studies of peptides from diverse therapeutic fields, and the lessons to be learned from them, while the final part looks at new targets and opportunities, discussing several drug targets and diseases for which peptide drugs are currently being developed.
Clearly structured into three major parts, the book stakes out the boundaries of peptide drug development in the preclinical as well as clinical stages. The first part provides a general background and focuses on the characteristic strengths and weaknesses of peptide drugs. The second section contains five cases studies of peptides from diverse therapeutic fields, and the lessons to be learned from them, while the final part looks at new targets and opportunities, discussing several drug targets and diseases for which peptide drugs are currently being developed.
Produkteigenschaften
- Artikelnummer: 9783527328918
- Medium: Buch
- ISBN: 978-3-527-32891-8
- Verlag: Wiley VCH Verlag GmbH
- Erscheinungstermin: 05.10.2011
- Sprache(n): Englisch
- Auflage: 1. Auflage 2011
- Produktform: Gebunden
- Gewicht: 884 g
- Seiten: 370
- Format (B x H x T): 179 x 251 x 25 mm
- Ausgabetyp: Kein, Unbekannt